SEC Form 4 research
| Issuer | Rapport Therapeutics, Inc. |
|---|---|
| Tickers | RAPP |
| Reporting owners | 30 |
| Officers and directors | 9 |
| Last public filing | 2026-10-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-08 | 2026-10-07 | Ceesay Abraham | S | 1,147 | $30.66 | Not reported |
| 2026-10-08 | 2026-10-06 | Ceesay Abraham | S | 3,375 | $32.03 | Not reported |
| 2026-10-01 | 2026-09-30 | Gault Cheryl | S | 2,075 | $33.76 | Not reported |
| 2026-10-01 | 2026-09-30 | Gault Cheryl | S | 7,925 | $33.04 | Not reported |
| 2026-09-24 | 2026-09-23 | Ceesay Abraham | S | 43 | $41.05 | Not reported |
| 2026-09-24 | 2026-09-23 | Ceesay Abraham | S | 215 | $39.86 | Not reported |
| 2026-09-24 | 2026-09-23 | Ceesay Abraham | S | 1,952 | $39.05 | Not reported |
| 2026-09-09 | 2026-09-08 | Ceesay Abraham | S | 1,069 | $46.01 | Not reported |
| 2026-09-09 | 2026-09-08 | Ceesay Abraham | S | 7,141 | $45.56 | Not reported |
| 2026-08-26 | 2026-08-25 | Ceesay Abraham | S | 18,921 | $49.57 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.